Search - tctmd.com

Displaying 561 - 580 of 892

Sort: Relevancy | Date

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

April 18, 2018

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

News Daily News

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

Michael O'Riordan

April 16, 2018

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

News Daily News

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Michael O'Riordan

April 09, 2018

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

March 29, 2018

No Increase in Long-term Cardiac Mortality After PCI for Women Compared With Men

News Daily News

No Increase in Long-term Cardiac Mortality After PCI for Women Compared With Men

March 21, 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

News Conference News ACC 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Michael O'Riordan

March 12, 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

News Conference News ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Michael O'Riordan

March 10, 2018

Wearable Cardioverter-Defibrillator Fails to Meet Primary Endpoint in First Randomized Trial

News Conference News ACC 2018

Wearable Cardioverter-Defibrillator Fails to Meet Primary Endpoint in First Randomized Trial

March 10, 2018

Could NOACs Have a Role for Secondary Prevention After STEMI?

News Daily News

Could NOACs Have a Role for Secondary Prevention After STEMI?

February 08, 2018

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

News Daily News

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Michael O'Riordan

February 02, 2018

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

News Daily News

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

February 01, 2018

‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large

News Daily News

‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large

Michael O'Riordan

January 30, 2018

More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs

News Conference News ISC 2018

More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs

January 27, 2018

Cardiovascular Health of US Stroke Survivors Is Worsening

News Conference News ISC 2018

Cardiovascular Health of US Stroke Survivors Is Worsening

January 26, 2018

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

News Conference News ISC 2018

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

January 25, 2018

Updated Stroke Guidelines Incorporate Just-Published Evidence Supporting Late-Window Thrombectomy

News Conference News ISC 2018

Updated Stroke Guidelines Incorporate Just-Published Evidence Supporting Late-Window Thrombectomy

January 24, 2018

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

News Daily News

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Michael O'Riordan

January 24, 2018

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.